Department of Neurosurgery, Sant'Anna University Hospital, Ferrara, Italy.
Department of Neurosurgery, Sant'Anna University Hospital, Ferrara, Italy.
Clin Neurol Neurosurg. 2021 Nov;210:107004. doi: 10.1016/j.clineuro.2021.107004. Epub 2021 Oct 24.
Different Dorsal root entry zone (DREZ) lesion techniques have been reported as effective treatment for intractable painful conditions, though with contradictory results. Overall, good results were reported especially in specific conditions, such as pain due to brachial plexus avulsion, spinal cord injuries and oncological pain management. However, data on long term results in different clinical conditions are still missing.
This study aims to systematically review the pertinent literature to evaluate indications, clinical outcomes, and complications of DREZ lesion (DREZotomy), in chronic pain management.
A systematic literature review was conducted according to the PRISMA statement. Papers on DREZotomy for chronic pain in cancer, brachial plexus avulsion, spinal cord injury, post herpetic neuralgia, and phantom limb pain were considered for eligibility. For each category we further identified two sub-group according to the length of follow up: medium term and long term follow up (more than 3 years) respectively.
46 papers, and 1242 patients, were included in the present investigation. When considering long term results DREZotomy provided favorable clinical outcomes in brachial plexus avulsion and spinal cord injury, in 60.8% and 55.8% of the cases respectively. Conversely, the success rate was 35.3% in phantom limb pain and 28.2% in post herpetic neuralgia. A poor clinical outcome was reported in over than 25% of the patients suffering from phantom limb pain, post herpetic neuralgia and spinal cord injury. The mean complications rate was 23.58%. While BPA and SCI patients presented stable improvement over time, good outcomes among PHN and PLP groups dropped by - 46.2%; and - 14.7% at long term follow up respectively.
DREZotomy seems to be an effective treatment for chronic pain conditions, especially for brachial plexus avulsion, spinal cord injury and intractable cancer/post-radiation pain. According to the low level of evidence of the pertinent literature, further studies are strongly recommended, to better define potential benefits and limitations of this technique.
不同的背根进入区(DREZ)损伤技术已被报道为治疗难治性疼痛的有效方法,但结果相互矛盾。总的来说,在某些特定情况下(如臂丛神经撕脱伤、脊髓损伤和肿瘤疼痛管理引起的疼痛)报告了良好的效果。然而,不同临床情况下长期结果的数据仍然缺失。
本研究旨在系统回顾相关文献,以评估 DREZ 损伤(DREZotomy)在慢性疼痛管理中的适应证、临床结果和并发症。
根据 PRISMA 声明进行系统文献回顾。考虑将 DREZotomy 用于癌症、臂丛神经撕脱伤、脊髓损伤、疱疹后神经痛和幻肢痛的慢性疼痛的论文符合入选标准。对于每一类,我们根据随访时间进一步分为两个亚组:中期和长期随访(超过 3 年)。
本次调查共纳入 46 篇论文和 1242 例患者。考虑长期结果时,DREZotomy 在臂丛神经撕脱伤和脊髓损伤中提供了有利的临床效果,分别在 60.8%和 55.8%的病例中。相反,在幻肢痛和疱疹后神经痛中成功率分别为 35.3%和 28.2%。在超过 25%的幻肢痛、疱疹后神经痛和脊髓损伤患者中报告了不良的临床结果。平均并发症发生率为 23.58%。虽然 BPA 和 SCI 患者随着时间的推移呈现出稳定的改善,但 PHN 和 PLP 组的良好结果分别下降了-46.2%和-14.7%。
DREZotomy 似乎是治疗慢性疼痛的有效方法,特别是对于臂丛神经撕脱伤、脊髓损伤和难治性癌症/放疗后疼痛。根据相关文献的低证据水平,强烈建议进行进一步的研究,以更好地确定该技术的潜在益处和局限性。